Related Experiment Videos

Heterogeneity of estrogen receptor in primary breast carcinoma evaluated by computed image analysis

J Simony, J L Pujol, J Grenier

American Journal of Clinical Pathology

|October 1, 1989

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Differential benefit of adjuvant everolimus according to endocrine therapy backbone in the randomized UNIRAD trial.

ESMO open·2025

Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ENGOT-ov25 trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2024

Prognostic value of EndoPredict test in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative primary breast cancer screened for the randomized, double-blind, phase III UNIRAD trial.

ESMO open·2024

Alpelisib and fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the French early access program.

Oncogene·2023

Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2018

A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1).

Annals of oncology : official journal of the European Society for Medical Oncology·2016

See all related articles